|
Reason for the notification
|
|
|
Initial notification /Amendment
|
Initial notification
|
|
Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
|
|
|
Name
|
Smith & Nephew plc
|
|
LEI
|
213800ZTMDN8S67S1H61
|
|
Details of the transaction(s): section to be repeated for (i) each
type of instrument; (ii) each type of transaction; (iii) each date;
and (iv) each place where transactions have been
conducted
|
|
|
Description of the financial instrument, type of
instrument
|
Smith & Nephew plc ordinary shares of USD 0.20
each
|
|
Identification code
|
ISIN: GB0009223206
|
|
Nature of the transaction
|
Purchase of ordinary shares through the Company’s Dividend
Re-Investment Plan following the 2026 interim dividend payment on 6
November 2026.
|
|
Date of Transaction
|
2026 – 11 – 06
|
|
Place of Transaction
|
London Stock Exchange (XLON)
|
|
Name (Position)
|
Director / PDMR
|
Price
|
Volume
|
Aggregated information
|
|
Deepak Nath (Chief Executive Officer)
|
Director
|
11.676693
|
4354.91595
|
N/A Single Transaction
|
|
Scott Schaffner (President, Sports Medicine)
|
PDMR
|
11.676693
|
1400.18596
|
N/A Single Transaction
|
|
Paul Connolly (President, Global Operations)
|
PDMR
|
11.676693
|
775.61555
|
N/A Single Transaction
|
|
Ajay Dhankhar (Chief Strategy & Corporate Development
Officer)
|
PDMR
|
11.676693
|
210.78942
|
N/A Single Transaction
|
|
Alison Parkes (Chief Compliance Officer)
|
PDMR
|
11.676693
|
100.10139
|
N/A Single Transaction
|
|
|
|
|
|
|
|
Smith & Nephew plc
|
|
|
|
(Registrant)
|
|
|
|
|
|
|
|
|
|
Date:
November 11, 2026
|
By:
|
/s/
Helen Barraclough
|
|
|
|
Helen
Barraclough
|
|
|
|
Company
Secretary
|